Cytotoxic T-lymphocyte Associated Antigen 4 Polymorphism and Hashimoto's Thyroiditis Susceptibility: a Meta-analysis

Overview

Journal Endocrine

Specialty Endocrinology

Date 2013 May 17

PMID 23677500

Citations 9

Authors

Hao Qiu

Weifeng Tang

Pengfei Yin

Feng Cheng

Lixin Wang

Affiliations

Soon will be listed here.

Abstract

The association between cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) exon-1 +49 A/G polymorphism and Hashimoto's thyroiditis (HT) has been widely studied. The results, however, are mixed. This study provides a comprehensive evaluation of the relationship between the genetic risks of CTLA-4 +49 A/G polymorphism and HT. A meta-analysis was conducted in over 4,600 subjects included in 18 case-control studies that were published up to November 15th, 2012. Our meta-analysis indicated that the CTLA-4 genotype was associated with the risk of HT in the allele comparison, homozygote comparison, heterozygote comparison, the dominant genetic model and the recessive genetic model. In the dominant genetic model, variant G allele carriers (GG + GA) of CTLA-4 +49 A/G polymorphism increased the risk of HT comparing to the homozygote AA [odds ratio (OR) = 1.70, 95% confidence interval (CI) 1.37-2.12 for GG + AG vs. AA]. The analysis by ethnicity groups suggested that Asian population (OR = 2.13, 95% CI 1.48-3.07 for GG + AG vs. AA) and Caucasian population (OR = 1.47, 95% CI 1.13-1.91 for GG + AG vs. AA) had significant increased HT risks. The association remained significant after adjusting for publication bias using the trim and fill method. Sensitivity analysis showed that the results were less stable, suggesting that these results should be explained with caution. In summary, this meta-analysis suggested that CTLA-4 +49 A/G polymorphism may be a risk factor for HT.

Citing Articles

Current understanding of CTLA-4: from mechanism to autoimmune diseases.

Hossen M, Ma Y, Yin Z, Xia Y, Du J, Huang J Front Immunol. 2023; 14:1198365.

PMID: 37497212 PMC: 10367421. DOI: 10.3389/fimmu.2023.1198365.

The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation.

Rosik J, Szostak B, Machaj F, Pawlik A Int J Mol Sci. 2021; 22(6).

PMID: 33802937 PMC: 8002677. DOI: 10.3390/ijms22063081.

Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?.

Zeber-Lubecka N, Hennig E Front Immunol. 2021; 12:606620.

PMID: 33746952 PMC: 7968419. DOI: 10.3389/fimmu.2021.606620.

CTLA-4 rs231775 and risk of acute renal graft rejection: an updated meta-analysis with trial sequential analysis.

Cargnin S, Galli U, Shin J, Terrazzino S Sci Rep. 2020; 10(1):12850.

PMID: 32732985 PMC: 7393166. DOI: 10.1038/s41598-020-69849-4.

Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.

Fathima N, Narne P, Ishaq M Endocrine. 2019; 64(3):591-604.

PMID: 30771152 DOI: 10.1007/s12020-019-01859-3.

References

Kouki T, Sawai Y, Gardine C, Fisfalen M, Alegre M, DeGroot L . CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000; 165(11):6606-11. DOI: 10.4049/jimmunol.165.11.6606. View

Lee H, Kang J, Yang S, Kim D, Park Y . Susceptibility influence of a PTPN22 haplotype with thyroid autoimmunity in Koreans. Diabetes Metab Res Rev. 2011; 27(8):878-82. DOI: 10.1002/dmrr.1265. View

Vieland V, Huang Y, Bartlett C, Davies T, Tomer Y . A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. Am J Hum Genet. 2008; 82(6):1349-56. PMC: 2427261. DOI: 10.1016/j.ajhg.2008.04.017. View

Farra C, Awwad J, Fadlallah A, Sebaly G, Hage G, Souaid M . Genetics of autoimmune thyroid disease in the Lebanese population. J Community Genet. 2012; 3(4):259-64. PMC: 3461226. DOI: 10.1007/s12687-012-0085-1. View

Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M . Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab. 1997; 82(12):4130-2. DOI: 10.1210/jcem.82.12.4406. View

Benhatchi K, Jochmanova I, Habalova V, Wagnerova H, Lazurova I . CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature. Clin Rheumatol. 2011; 30(10):1319-24. DOI: 10.1007/s10067-011-1752-z. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Tandon N, Zhang L, Weetman A . HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 1991; 34(5):383-6. DOI: 10.1111/j.1365-2265.1991.tb00309.x. View

Kucharska A, Wisniewska A, Popko K, Demkow U . Association between the polymorphism A/G at position 49 of exon 1 of the CTLA-4 gene and antithyroid antibody production in children with Hashimoto's thyroiditis. Horm Res Paediatr. 2012; 78(2):67-72. DOI: 10.1159/000338997. View

10.

Petrone A, Giorgi G, Mesturino C, Capizzi M, Cascino I, Nistico L . Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid. 2001; 11(2):171-5. DOI: 10.1089/105072501300042901. View

11.

Zaletel K, Krhin B, Gaberscek S, Bicek A, Pajic T, Hojker S . Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis. Clin Exp Immunol. 2010; 161(1):41-7. PMC: 2940147. DOI: 10.1111/j.1365-2249.2010.04113.x. View

12.

Tomer Y . Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010; 20(7):715-25. PMC: 2949235. DOI: 10.1089/thy.2010.1644. View

13.

Buonavista N, Balzano C, Pontarotti P, Le Paslier D, Golstein P . Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics. 1992; 13(3):856-61. DOI: 10.1016/0888-7543(92)90169-s. View

14.

Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C . Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes. 1998; 47(1):128-9. DOI: 10.2337/diab.47.1.128. View

15.

Kolar P, Knieke K, Hegel J, Quandt D, Burmester G, Hoff H . CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 2009; 60(1):123-32. DOI: 10.1002/art.24181. View

16.

Szyper-Kravitz M, Marai I, Shoenfeld Y . Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005; 38(3):247-55. DOI: 10.1080/08916930500050194. View

17.

Jacobson E, Tomer Y . The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun. 2007; 28(2-3):85-98. PMC: 2043086. DOI: 10.1016/j.jaut.2007.02.006. View

18.

Dallos T, Avbelj M, Barak L, Zapletalova J, Pribilincova Z, Krajcirova M . CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease. Neuro Endocrinol Lett. 2008; 29(3):334-40. View

19.

Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G . Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939):506-11. DOI: 10.1038/nature01621. View

20.

Tomoyose T, Komiya I, Takara M, Yabiku K, Kinjo Y, Shimajiri Y . Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto's thyroiditis in Japanese patients. Thyroid. 2002; 12(8):673-7. DOI: 10.1089/105072502760258640. View